# Epitalon

Four amino acids designed in St Petersburg to copy a pineal-gland extract. It is sold as a longevity peptide that lengthens telomeres, a claim that rests on cells in a dish. Nearly every human study comes from the institute that invented it.

Also called: Epithalon, AEDG peptide
Source page: https://peplogue.com/peptides/epitalon/
Reviewed: 2026-10-12. Not medical advice.

## How it works

- Where it acts: Thought to switch on telomerase, the enzyme that rebuilds telomeres.
- What it changes: Longer telomeres in cells grown in a dish.
- What people notice: No independent human trial, so effects in people are unknown.

## What the evidence shows

- **Longer telomeres and longer life**: Lab only. No human trial shows longer telomeres or longer life.
- **Melatonin and sleep**: Early. One placebo-controlled study in 75 women found a 1.6-fold rise in a melatonin marker. Sleep was not an outcome.
- **Retinitis pigmentosa**: Early. One study of 162 patients against usual treatment, with no clear randomization or blinding.

## Side effects and risks

- unknown: Nobody has studied whether a compound meant to switch on telomerase could encourage cancer.
- unknown: FDA says it has found no safety information for it.

Who should avoid it: Anyone with a history of cancer.

## How it has been given in studies

Under the tongue for 20 days, or injected beside the eye for 10 days. No study has worked out a dose for injection under the skin.

## Legal status

- United States: undefined. Advisers backed compounding in July 2026. FDA staff opposed it, and FDA had not acted by late September 2026.
- European Union: undefined
- Spain: undefined. No epitalon medicine in CIMA. Research peptide, not authorised in Spain and not lawful to sell to the public.
- Germany: undefined. Not approved in Germany. Selling it as a medicine without approval is a crime (AMG § 21, § 96); sold online only as 'research' products.
- France: undefined. No French authorisation found. Not named by ANSM, but its Jul 2026 alert says peptides bought outside the official circuit are illegal.
- Italy: undefined. No Italian authorisation found. Not lawful to sell to the public as a medicine. Research-grade vials online are unverified products.
- Netherlands: undefined. No Dutch marketing authorisation found. Selling it as a medicine without one is illegal per IGJ, even if labelled 'research use'.
- United Kingdom: undefined
- Canada: undefined
- Australia: undefined

## Questions people ask

**Does Epitalon lengthen telomeres?**

Only in cells grown in a dish. No human trial shows longer telomeres or longer life, and nearly every human study comes from the institute that invented it.

**Does Epitalon help sleep?**

One placebo-controlled study in 75 women found a 1.6-fold rise in a melatonin marker, but sleep was not an outcome. Users report better sleep and vivid dreams.

**Is Epitalon safe?**

FDA says it has found no safety information for it. Nobody has studied whether a compound meant to switch on telomerase could encourage cancer, so people with a history of cancer are advised to avoid it.

**Is Epitalon legal in the US?**

FDA advisers voted 7 to 4 in July 2026 to back compounding, but FDA staff opposed it and FDA had not acted by late September 2026.

## Sources

- Araj et al. 2025: review of Epitalon: https://www.mdpi.com/1422-0067/26/6/2691
- FDA: bulk substances that may present significant safety risks: https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- McDermott: July 2026 advisory committee votes: https://www.mcdermottlaw.com/insights/bulk-list-bound-pcac-backs-majority-of-peptides-in-two-day-public-meeting/